Archive for December 6th, 2020

Olympus Acquires Veran Medical Technologies, Inc.

Olympus Acquires Veran Medical Technologies, Inc.

06-Dec-2020 Intellasia | ACN Newswire | 6:51 PM

TOKYO, JP & CENTER VALLEY, PA, Dec 7, 2020 - (ACN Newswire) - Olympus Corporation (TSE: 7733) today announced that it has entered into an agreement to acquire Veran [...] » More

CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition

06-Dec-2020 Intellasia | PR Newswire Asia | 6:00 PM

SHANGHAI, Dec. 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company, announced updated safety and [...] » More

Rimba Raya’s Sustainable Peatland Farmer Field School

Rimba Raya’s Sustainable Peatland Farmer Field School

06-Dec-2020 Intellasia | ACN Newswire | 4:05 PM

Central Kalimantan, INDONESIA, Dec 6, 2020 - (ACN Newswire) - In November 2020, Rimba Raya Biodiversity Reserve (Rimba Raya) conducted training sessions aimed at [...] » More

The 3rd Hainan Island International Film Festival opened in Sanya, Hainan, China

The 3rd Hainan Island International Film Festival opened in Sanya, Hainan, China

06-Dec-2020 Intellasia | BusinessWire | 3:10 PM

SANYA, Hainan, China--(BUSINESS WIRE)--On December 5th, the 3rd Hainan Island International Film Festival opened in Sanya, Hainan, China. Shen Xiaoming, secretary of Hainan [...] » More

Youth Co:Lab Hong Kong Dialogue Empowers Equal Future for Youth

Youth Co:Lab Hong Kong Dialogue Empowers Equal Future for Youth

06-Dec-2020 Intellasia | Media OutReach | 11:00 AM

A city-wide discourse to inspire youth-led movement towards social inclusion and social entrepreneurship HONG KONG - Media OutReach - 6 December 2020 - The 2020 Youth [...] » More

Gracell Biotechnologies Announces Presentation of First-in-Human Data of GC012F a First-in-Class FasTCAR-enabled Dual-targeting BMCA/CD19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Multiple Myeloma at 2020 ASH Annual Meeting

Gracell Biotechnologies Announces Presentation of First-in-Human Data of GC012F a First-in-Class FasTCAR-enabled Dual-targeting BMCA/CD19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Multiple Myeloma at 2020 ASH Annual Meeting

06-Dec-2020 Intellasia | PR Newswire Asia | 3:30 AM

SUZHOU and SHANGHAI, China, Dec. 6, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a [...] » More